Keyphrases
Glioblastoma
100%
Tumor
84%
Medulloblastoma
79%
Sex Differences
71%
Brain Tumor
57%
Glioma
49%
Neurofibromatosis Type 1 (NF-1)
48%
C-X-C Chemokine Receptor Type 4 (CXCR4)
46%
Mouse Model
37%
Sex-specific
35%
In Cancer
35%
Focused Ultrasound
32%
Chemokine Ligand 12 (CXCL12)
32%
Sonic Hedgehog
31%
Pediatric Brain Tumor
28%
Temozolomide
28%
Neurofibromatosis Type I
27%
Radiation Therapy
24%
Glioma Growth
23%
Overall Survival
22%
Primary Brain Tumor
19%
Tumor Cells
19%
Pediatric
18%
Optic Pathway Glioma
18%
Astrocytes
17%
Tumor Growth
17%
Gliomagenesis
17%
Newly Diagnosed Glioblastoma
16%
Progression-free Survival
15%
Metabolism
14%
Blood-brain Barrier
13%
Endothelial Cells
13%
Sexually Dimorphic
13%
Functional Connectivity
13%
Cyclic Adenosine Monophosphate (cAMP)
13%
Diffuse Intrinsic Pontine Glioma
13%
Pilocytic Astrocytoma
13%
Chemotherapy
13%
Gross Total Resection
13%
Microenvironment
13%
Gold Nanoclusters
12%
Malignant Glioma
12%
Sonic Hedgehog Medulloblastoma
12%
Glioma Risk
12%
Medulloblastoma Subgroups
12%
Brain Tumorigenesis
11%
Brainstem
11%
Glioma Model
11%
Resting-state Functional Connectivity (rs-FC)
11%
Disulfiram
11%
Medicine and Dentistry
Neoplasm
88%
Ganglioglioma
55%
Medulloblastoma
49%
Glioblastoma
47%
Intracranial Tumor
42%
Malignant Neoplasm
37%
Sex Difference
35%
Pediatrics
31%
Neurofibromatosis Type I
28%
Diseases
28%
Overall Survival
21%
Surgery
21%
Sonic Hedgehog Protein
19%
Carcinogenesis
17%
Tumor Progression
16%
Radiation Therapy
14%
Cancer
14%
Treatment Response
13%
Pilocytic Astrocytoma
13%
Biopsy Technique
13%
Blood Brain Barrier
12%
Pediatric Brain Tumor
12%
Gender and Sex
11%
Copper 64
11%
Bevacizumab
10%
Endothelial Cell
10%
Progression Free Survival
9%
Medicine
9%
Temozolomide
8%
Tumor Cell
8%
Recurrent Disease
7%
Functional Connectivity
7%
Meningioma
7%
Pontine Glioma
7%
Nervous System Tumor
7%
Angiogenesis Inhibitor
7%
Prognostic Factor
7%
Gene Mutation
6%
Clinical Trial
6%
Central Nervous System Tumor
6%
Sex Hormone
6%
U87
5%
Platelet Derived Growth Factor Receptor
5%
Cell Interaction
5%
Quality of Life
5%
Epidermal Growth Factor Receptor
5%
Positron Emission Tomography
5%
Antiangiogenic
5%
Cancer Therapy
5%
Chronotherapy
5%